Source: Cost Effectiveness and Resource Allocation. Unidade: IME
Subjects: REAMOSTRAGEM BOOTSTRAP, DOENÇAS CARDIOVASCULARES, REVASCULARIZAÇÃO MIOCÁRDICA
ABNT
BRANDÃO, Sara Michelly Gonçalves et al. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial. Cost Effectiveness and Resource Allocation, v. 16, n. 55, p. 1-14, 2018Tradução . . Disponível em: https://doi.org/10.1186/s12962-018-0158-z. Acesso em: 26 set. 2024.APA
Brandão, S. M. G., Rezende, P. C., Brunner-La Rocca, H. -P., Ju, Y. T., Lima, A. C. P. de, Takiuti, M. E., et al. (2018). Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial. Cost Effectiveness and Resource Allocation, 16( 55), 1-14. doi:10.1186/s12962-018-0158-zNLM
Brandão SMG, Rezende PC, Brunner-La Rocca H-P, Ju YT, Lima ACP de, Takiuti ME, Hueb W, Bocchi EA. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial [Internet]. Cost Effectiveness and Resource Allocation. 2018 ;16( 55): 1-14.[citado 2024 set. 26 ] Available from: https://doi.org/10.1186/s12962-018-0158-zVancouver
Brandão SMG, Rezende PC, Brunner-La Rocca H-P, Ju YT, Lima ACP de, Takiuti ME, Hueb W, Bocchi EA. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial [Internet]. Cost Effectiveness and Resource Allocation. 2018 ;16( 55): 1-14.[citado 2024 set. 26 ] Available from: https://doi.org/10.1186/s12962-018-0158-z